Disease data from ECDC Surveillance Atlas
Get the latest surveillance data on Meningococcal disease from EU and EEA countries through the Surveillance Atlas of Infectious Diseases.Get the data.
Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, ItalyArchived
Threats and outbreaks
Disease threats and outbreaks reports; Communicable disease threats report, Risk assessments.
ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods.
Systematic reviews, expert opinions and public health guidance on meningococcal disease
Prevention and control
Vaccines are available against serogroups A, B, C, Y and W. Most instances of the disease in Europe are caused by serogroups B and C.
ECDC Vaccine Scheduler
The Vaccine Scheduler is an interactive tool that shows vaccination schedules for individual EU/EEA countries and specific age groups. With this tool comparisons can be made for vaccination schedules between two countries or by disease for all or a selection of countries.Read more